Flexion Therapeutics Inc
FLXNDelisted Nov 19, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419600
Flexion Therapeutics Inc was delisted on Nov 19, 2021; its insiders filed their last Form 4 on Nov 23, 2021; 145 institutions reported holding it in 13F filings for Q3 2021, worth $230.4M in total; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 145
- Q3 2021, +7 vs. previous quarter
- 13F value
- $230.4M
- Reported value at the end of Q3 2021
- Superinvestors holding
- 0
- At the end of Q3 2021
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2020
- $85.6M
- +17.3% year over year
- Net income, FY2020
- -$113.7M
- No comparable prior period
- Free cash flow, FY2020
- -$80.6M
- No comparable prior period
- Revenue, Q3 FY2021
- $21.3M
- −9.9% year over year
Revenue flow, FY2020
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2020: $113.7M (132.9% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.09K
- Shares sold short
- Change
- +223
- +25.8% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding FLXN, Q3 2021
Go to the superinvestors tabNo superinvestor reported holding FLXN at the end of Q3 2021.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Flexion Therapeutics Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Willwerth ChristinaChief Strategy Officer | SSale | −3.94K | $6.45 | −$25.4K | −2.7%141.2K after | |
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Wentworth KerryChief Regulatory Officer | SSale | −3.94K | $6.45 | −$25.4K | −2.7%140.4K after | |
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Muzikant AdamChief Business Officer | SSale | −1.87K | $6.45 | −$12.1K | −1.8%103.7K after | |
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Levine Mark S.General Counsel | SSale | −3.94K | $6.45 | −$25.4K | −2.9%133.5K after |
Top 10 13F holders, Q3 2021
See all 145 holdersThe largest institutional positions in Flexion Therapeutics Inc at the end of Q3 2021; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 4,296,333 | $26.2M | 0.00% | +2,278+0.1% | Added |
| Wasatch Advisors Inc | 3,594,167 | $21.9M | 0.09% | −591,278−14.1% | Reduced |
| OrbiMed Advisors LLC | 2,769,383 | $16.9M | 0.19% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,588,032 | $15.8M | 0.00% | −15,256−0.6% | Reduced |
| Soleus Capital Management, L.P. | 2,084,050 | $12.7M | 1.98% | +2,084,050 | New |
| Clearline Capital LP | 1,910,153 | $11.7M | 1.53% | −213,546−10.1% | Reduced |
| Novo Holdings A/S | 1,403,370 | $8.56M | 0.44% | 00.0% | Unchanged |
| Granahan Investment Management Inc | 1,233,194 | $7.52M | 0.14% | −180,109−12.7% | Reduced |
| State Street Corp | 1,153,373 | $7.04M | 0.00% | −2,823,331−71.0% | Reduced |
| Geode Capital Management, LLC | 1,058,094 | $6.45M | 0.00% | +226,660+27.3% | Added |
Politician trades
All politician trades in FLXN1 member of Congress reported 10 trades in Flexion Therapeutics Inc since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Aug 26, 2021 |  Tom Malinowski House · NJ | Buy | $1K-$15K |
| Aug 26, 2021 | Tom Malinowski House · NJ | Sell | $1K-$15K |
| Aug 26, 2021 | Tom Malinowski House · NJ | Sell | $1K-$15K |
| Jul 9, 2021 | Tom Malinowski House · NJ | Sell | $1K-$15K |
| Jul 9, 2021 | Tom Malinowski House · NJ | Sell | $1K-$15K |
House · NJ · Aug 26, 2021
Buy$1K-$15K
House · NJ · Aug 26, 2021
Sell$1K-$15K
House · NJ · Aug 26, 2021
Sell$1K-$15K
House · NJ · Jul 9, 2021
Sell$1K-$15K
House · NJ · Jul 9, 2021
Sell$1K-$15K